Complete reversal of nephrotic syndrome secondary to amyloidosis with use of infliximab in a patient with inflammatory bowel disease and ankylosing spondylitis

8Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 30-year-old woman was diagnosed with ulcerative colitis in January 2006. One year later, she presented because of severe back pain and was diagnosed with ankylosing spondylitis (AS). In February 2008, the patient, while still under standard treatment for ulcerative colitis and AS, was admitted because of massive proteinuria and related symptoms. Nephrotic syndrome was observed and renal biopsy revealed amyloid deposits. After treatment with infliximab, nephrotic syndrome disappeared. We aim to present a case of secondary amyloidosis complicating ulcerative colitis and associated spondyloarthropathy. Copyright © 2011 Informa Healthcare USA, Inc.

Cite

CITATION STYLE

APA

Akdǒan, M. F., Gücün, M., Denizli, N., Güney, M., Akdag, I., Öözcan, T. B., & Duranay, M. (2011). Complete reversal of nephrotic syndrome secondary to amyloidosis with use of infliximab in a patient with inflammatory bowel disease and ankylosing spondylitis. Renal Failure, 33(5), 531–533. https://doi.org/10.3109/0886022X.2011.577543

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free